MyChesCo on MSN7h
Johnson & Johnson Showcases Promising Data on Nipocalimab for gMG at AAN Annual MeetingJohnson & Johnson presented new data on its investigational treatment, nipocalimab, at the 2025 American Academy of Neurology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback